Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Vaxcyte Inc

5VA
Current price
95 EUR 0 EUR (0.00%)
Last closed 104.07 USD
ISIN US92243G1085
Sector Healthcare
Industry Biotechnology
Exchange Frankfurt Exchange
Capitalization 13 280 677 888 USD
Yield for 12 month +102.96 %
1Y
3Y
5Y
10Y
15Y
5VA
21.11.2021 - 28.11.2021

Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine for the prevention of invasive pneumococcal disease. The company also develops VAX-31 to protect against emerging strains and to help address antibiotic resistance; VAX-A1, a novel conjugate vaccine candidate to prevent disease caused by Group A Streptococcus; VAX-PG, a novel protein vaccine candidate targeting keystone pathogen responsible for periodontitis; and VAX-GI to prevent Shigella, a bacterial illness. The company was formerly known as SutroVax, Inc. and changed its name to Vaxcyte, Inc. in May 2020. Vaxcyte, Inc. was incorporated in 2013 and is headquartered in San Carlos, California. Address: 825 Industrial Road, San Carlos, CA, United States, 94070

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

149.29 USD

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

-75 000 000 USD

Last Year

-9 196 000 USD

Current Quarter

-3 478 000 USD

Last Quarter

-3 091 000 USD

Key Figures 5VA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -573 110 976 USD
Operating Margin TTM
PE Ratio
Return On Assets TTM -20.1 %
PEG Ratio
Return On Equity TTM -29.08 %
Wall Street Target Price 149.29 USD
Revenue TTM
Book Value 17.96 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM -22 995 000 USD
Earnings per share -4.69 USD
Diluted Eps TTM -4.69 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics 5VA

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History 5VA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation 5VA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA -14.4283
Price Book MRQ 6.6867

Financials 5VA

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators 5VA

For 52 weeks

46.16 USD 121.06 USD
50 Day MA 108.91 USD
Shares Short Prior Month 9 651 135
200 Day MA 81.17 USD
Short Ratio 12.28
Shares Short 9 344 117
Short Percent 8.58 %